Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents.

about

Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery.Identification of -Benzyl 3,5-Dinitrobenzamides Derived from PBTZ169 as Antitubercular Agents

P2860

Q52578227-1803A82B-9030-425E-A4A9-FC0CB5142C13 Q57179149-665B5434-81E3-4939-8913-C22750E7F14B

P2860

Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents.

Item

http://www.wikidata.org/entity/Q38669601

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Identification of Better Pharm ...... as New Antitubercular Agents.

@en

type

Item

label

Identification of Better Pharm ...... as New Antitubercular Agents.

@en

prefLabel

Identification of Better Pharm ...... as New Antitubercular Agents.

@en

P1476

Identification of Better Pharm ...... as New Antitubercular Agents.

@en

P2093

Apeng Wang

http://www.w3.org/2001/XMLSchema#string

Bin Wang

http://www.w3.org/2001/XMLSchema#string

Bo Wang

http://www.w3.org/2001/XMLSchema#string

Guocheng Huang

http://www.w3.org/2001/XMLSchema#string

Kai Lv

http://www.w3.org/2001/XMLSchema#string

Mingliang Liu

http://www.w3.org/2001/XMLSchema#string

Xuefu You

http://www.w3.org/2001/XMLSchema#string

Yu Lu

http://www.w3.org/2001/XMLSchema#string

Yun Chai

http://www.w3.org/2001/XMLSchema#string

Zengquan Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis

New agents for the treatment of drug-resistant Mycobacterium tuberculosis

Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis

Identification of a small molecule with activity against drug-resistant and persistent tuberculosis

Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

Decaprenylphosphoryl-β-D-ribose 2'-epimerase, the target of benzothiazinones and dinitrobenzamides, is an essential enzyme in Mycobacterium smegmatis

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis.

Clinical isolates of Mycobacterium tuberculosis in four European hospitals are uniformly susceptible to benzothiazinones

P304

636-641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSMEDCHEMLETT.7B00106

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28626525

http://www.w3.org/2001/XMLSchema#string

P932

5467196

http://www.w3.org/2001/XMLSchema#string

Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents.

about

P2860

P2860

Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932